| Document |
Document Title |
|
WO/2016/081589A2 |
The synthesis and in vitro and in vivo anti-breast and anti-prostate cancers activities of novel C-4 heteroaryl 13-cis retinamides that modulate Mnk-eIF4E and AR signaling are discussed. In both breast and prostate cancer cell lines, the...
|
|
WO/2016/078673A1 |
The present invention concerns a process for converting biomass into useful organic building blocks for the chemical industry. The process involves the reduction of a polyol wherein at least two of the hydroxyl groups are located on adja...
|
|
WO/2016/076801A1 |
A hydrophobic or superhydrophobic polymer composite comprising a Iattice of poiycyclic aromatic hydrocarbons such as reduced graphene oxide (rGO) modified with at least one siloxane polymer and a method of preparation thereof is disclose...
|
|
WO/2016/064590A1 |
In a process for dehydrogenating cyclohexylbenzene and/or alkyl-substituted cyclohexylbenzene compounds, a dehydrogenation catalyst comprising at least one Group 10 metal compound on a support is heated in the presence of hydrogen from a...
|
|
WO/2016/063972A1 |
Provided are: a resin additive composition that enables a fullerene to be dispersed and contained in various resins; a resin composition using the same; and a production method for said resin composition. The present invention uses a res...
|
|
WO/2016/064671A2 |
There is provided a compound having Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V), or Formula (VI).
|
|
WO/2016/058062A1 |
In general the present invention concerns a method for cyclo-depolymerisation of polybutadiene to large macrocycles by metathesis catalysts. More specifically this invention relates to a novel process for the degradation by olefin metath...
|
|
WO/2016/057606A1 |
The invention relates to processes for large-scale diastereoselective syntheses of cycloheptadienylsulfone and stereo tetrads, key intermediates for the preparation of Aplyronine A.
|
|
WO/2016/053466A1 |
Disclosed are processes for making cyclohexanone from a mixture comprising phenol, cyclohexanone, cyclohexylbenzene, and an S-containing component, comprising a step of removing at least a portion of the S-containing component to reduce ...
|
|
WO/2016/039510A1 |
The present invention relates to: an organic compound represented by a combination of chemical formulas 1 and 2; an organic optoelectronic device comprising the organic compound; and a display device.
|
|
WO/2016/039262A1 |
This method for producing a fullerene derivative is a method for producing a fullerene derivative having a partial structure shown by formula (1) by reacting a predetermined halogenated compound and two carbon atoms adjacent to each othe...
|
|
WO/2016/034261A1 |
The invention relates to novel mixtures of substituted fullerenes, to their use in organic electronic (OE) devices, especially organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising...
|
|
WO/2016/032274A1 |
Provided in the present invention are a novel fullerene derivative and an organic solar cell containing same. The novel fullerene derivative according to the present invention has high solubility with respect to an organic solvent and hi...
|
|
WO/2016/029888A1 |
The present invention provides amphiphilic compounds with tetradecahydrophenanthrene skeleton and their enantiomers, exhibiting neuroprotective effects, their use as medicaments for treating neuropsychiatric disorders associated with an ...
|
|
WO/2016/025219A1 |
Disclosed are processes for making cyclohexanone from a mixture comprising phenol, cyclohexanone, cyclohexylbenzene, and a catalyst poison component, comprising a step of removing at least a portion of the catalyst poison component to re...
|
|
WO/2016/019630A1 |
Disclosed is a method for synthesizing 1,3-disubstituted allene with high optical activity, namely a method for preparing 1,3-disubstituted allene with high optical activity in one step of functionalizing terminal alkyne, aldehyde and ch...
|
|
WO/2016/018795A1 |
Provided herein are brain penetrant histone deacetylase (HDAC) inhibitors useful for treating diseases or disorders associated with HDAC. An exemplary HDAC inhibitor provided herein exhibits a brain-to-plama ratio of 20: 1. Pharmaceutica...
|
|
WO/2016/013867A1 |
The present disclosure relates to an organic electroluminescent device. The organic electroluminescent device of the present disclosure shows high luminous efficiency and good lifespan by comprising a specific combination of the plural k...
|
|
WO/2016/013976A1 |
The invention relates to a method of forming a multi-substituted benzene compound. In particular, the method involves benzene construction via organocatalytic formal [3+3] cycloaddition reaction.
|
|
WO/2016/010746A1 |
There is disclosed a compound having Formula I. In Formula I: Ar1 and Ar3 are the same or different and are aryl groups; Ar2 and Ar4 are the same or different and are aryl groups; L is the same or different at each occurrence and can be ...
|
|
WO/2015/197585A1 |
The present invention is directed to methylation catalysts comprising gallium oxide, which preferably further contain magnesium oxide. In a preferred embodiment of the present invention, the methylation catalyst consists of gallium oxide...
|
|
WO/2015/190420A1 |
Provided is a cobalt complex which is useful for producing a cobalt-containing thin-film under conditions which do not use an oxidizing gas. The cobalt complex is represented by general formula (I). (In the formula, RA represents: an acy...
|
|
WO/2015/191291A1 |
A method of capturing a basic, nitrogen-containing compound is provided. The basic, nitrogen-containing compound is captured by sorption (e.g., adsorption) on a sulfonic-acid containing polymeric material. The sulfonic acid-containing po...
|
|
WO/2015/189073A1 |
The present invention relates to a new process for the synthesis of 2,3,4,5,6,7-substiuted indenes, which are useful precursors for the formation of certain ansa-metailocene catalysts.
|
|
WO/2015/162097A1 |
The present invention concerns a process for preparing cyclohexane from methylcyclopentane (MCP) and benzene. In the present invention, MCP and benzene are constituents of a hydrocarbon mixture (KG1) also including dimethylpentanes (DMP)...
|
|
WO/2015/159384A1 |
[Problem] To provide a novel compound, and a cosmetic, topical skin agent, etc. comprising same. [Solution] A compound represented by formula (1) (in the formula, n = an integer 1-8); and a cosmetic, topical skin agent, whitening agent, ...
|
|
WO/2015/151965A1 |
An organic electroluminescent element which comprises a positive electrode, a negative electrode and a light emitting layer, and wherein the light emitting layer contains a first compound, a second compound and a third compound. The sing...
|
|
WO/2015/146944A1 |
An organic-hydride-manufacturing device (10) according to a aspect of the present invention has an electrochemical cell provided with an anode (12) on one surface of an electrolyte film (11) and a cathode on the other surface of the elec...
|
|
WO/2015/147046A1 |
An extraction solvent for extractive distillation represented by general formula (1) used when separating any one of (a)-(c) by extractive distillation from a hydrocarbon mixture containing at least two selected from saturated aliphatic ...
|
|
WO/2015/145417A1 |
A novel delivery system for macromolecules such as proteins and oligonucleotides, and specifically siRNA through biological membranes is provided, comprising conjugation of the macromolecule to a moiety, which enables effective crossing ...
|
|
WO/2015/137289A1 |
The present invention pertains to spherical water-dispersible amorphous particles having a particle diameter of 10-990 nm and a PDI of 0.01-0.5, wherein the amorphous particles contain an organic compound having a molecular weight of 50-...
|
|
WO/2015/129228A1 |
[Problem] To reduce the circulated amount of unreacted material while suppressing excessive increase in temperature in a hydrogenation reaction in an aromatic compound hydrogenation system. [Solution] A hydrogenation system (1) is provid...
|
|
WO/2015/128052A1 |
The present invention relates to materials for use in electronic devices, in particular as a host material for phosphorescent emitters in organic light-emitting devices, and to electronic devices, in particular organic light-emitting dev...
|
|
WO/2015/120669A1 |
Disclosed is a composite catalyst used in preparing quadricyclane through photocatalytic isomerization of norbornadiene, the composite catalyst comprising: a solid photocatalyst selected from TiO2, Ti-MCM-41, Ti-SBA-15, ZnO, WO3, Ta2O5 o...
|
|
WO/2015/120670A1 |
Disclosed is a high-purity quadricyclane continuous preparation method, employing an integrated reaction and rectification method or a method of reaction before rectification. Both of the methods employ a novel composite catalyst obtaine...
|
|
WO/2015/115101A1 |
[Problem] To reduce an energy required for a treatment for decreasing the concentration of a high-boiling-point component (including a substance that is poisoned with a dehydrogenation catalyst) which is contained in a hydrogenated aroma...
|
|
WO/2015/113518A1 |
The present application provides a method of preparing high-purity borneol from lauraceae extract or blumea balsamifera extract. The method comprises using an aluminum alkoxide solution having a low boiling point to dissolve lauraceae ex...
|
|
WO/2015/115410A1 |
The present invention provides a novel hydrogenation reaction and hydrocracking reaction, and provides a technique that does not use separate, large-scale hydrogen supply equipment for the reaction and does not require high-pressure equi...
|
|
WO/2015/111611A1 |
This production method of a compound represented in formula (I) is characterized by deriving a para-phenylene ring from the compound represented in formula (II) by the 2- and 5-position OH groups bonded to a 1,3-cyclohexadiene ring being...
|
|
WO/2015/100267A1 |
Embodiments provided herein relate to methods and compositions for treating cancer. Some embodiments relate to certain compounds having activity against retinoid X receptor-alpha (RXRa). Some embodiments included designing or identifying...
|
|
WO/2015/094528A1 |
Disclosed is a composition cyclohexylbenzene composition comprising cyclohexylbenzene at a concentration of C(CHB) wt% and methylcyclopentylbenzene at a concentration of C(MCPB) ppm, where the percentage and ppm are based on the total we...
|
|
WO/2015/094952A1 |
Disclosed are (i) a process for making cyclohexylbenzene by benzene hydroalkylation with a low methylcyclopentylbenzene selectivity; and (ii) a process of making phenol and/or cyclohexanone from cyclohexylbenzene including a step of remo...
|
|
WO/2015/089853A1 |
A blue fluorescent organic material comprises an organic compound with a formula (I) structure. In the formula (I) structure, R is C1-C20 alkyl groups, C1-C20 alkoxy groups or C1-C20 aromatic groups containing substituent groups; Ar1 is ...
|
|
WO/2015/085720A1 |
Disclosed in the present invention are an anthracene-containing derivative, a preparation method therefor and an organic electroluminescent display. The anthracene-containing derivative has a general molecular structure of Formula I, whe...
|
|
WO/2015/086578A1 |
The invention relates to a method for processing a reaction mixture (RG) containing cyclododecatriene and an active catalyst system (K), which contains an aluminum-organic compound. Said method comprises the following steps: a) the react...
|
|
WO/2015/084114A1 |
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. By using the organic electroluminescent compound of the present disclosure, an organic electroluminesc...
|
|
WO/2015/079957A1 |
Provided is a method for producing a cyclic olefin compound that makes it possible to suppress isomerization reactions and other such secondary reactions, and to efficiently obtain a high-purity cyclic olefin compound containing few impu...
|
|
WO/2015/074137A1 |
The disclosure provides methods of treatment of ocular inflammation or neuropathic pain in a subject in need thereof, comprising administering to the subject in need thereof a CB2 target agent, a cannabimimetic agent (such as a non-psych...
|
|
WO/2015/074874A1 |
A method of preparation of a porogen composition comprising for 100% by weight: - at least 99,5% by weight of norbornadiene; - from 10 ppm to 500 ppm by weight of a nitroxyl radical based; - from 250 ppb to 10 ppm by weight of benzene, s...
|
|
WO/2015/076427A1 |
Disclosed is an integrated upgrading method wherein light olefins, such as ethylene and propylene, are efficiently prepared by economically collecting isoprene, piperylene, and cyclopentadiene, which are olefins useful in C5 mixed fracti...
|
